ARCHIVES

Golde To Step Down At MSK; Porter Joins Hogan & Hartson.

This article is from The Cancer Letter archive.

Vol. 27 No. 04 | January 26, 2001

Download PDF Visit The Full Archive

Related Articles

Biomarker Test Outperforms PSA and Gleason Score in Study

July 26, 2013

In Congress: $135 Million Expected For DOD Breast Cancer Research Program

July 24, 1998

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

July 13, 2007

FDA’s Jane Henney

February 11, 1994

Arzerra Given Accelerated Approval For Leukemia

October 30, 2009

In Brief: Congress Finished Spending Bill, Reagan Signs It; NCI Gets $1.402 Billion, a $174.5 Million Raise

October 24, 1986